HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meenakshi Rani Selected Research

Placebos

1/2017The composition of T-cell subsets are altered in the burn wound early after injury.
8/2014Gamma delta T cells regulate wound myeloid cell activity after burn.
1/2014Burn wound γδ T-cells support a Th2 and Th17 immune response.
11/2012Gamma delta (γδ) T-cells are critical in the up-regulation of inducible nitric oxide synthase at the burn wound site.
7/2010Increased expression of cardiac IL-17 after burn.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Meenakshi Rani Research Topics

Disease

10Burns
03/2017 - 07/2010
8Wounds and Injuries (Trauma)
01/2021 - 01/2006
4Inflammation (Inflammations)
11/2016 - 01/2012
2Lung Injury
01/2021 - 06/2015
2Shock
01/2019 - 01/2006
2Sepsis (Septicemia)
01/2011 - 05/2008
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Neoplasms (Cancer)
01/2022
1Hemorrhagic Shock
01/2019
1Reperfusion Injury
11/2013
1Myocarditis (Carditis)
07/2010
1Bacterial Infections (Bacterial Infection)
01/2006

Drug/Important Bio-Agent (IBA)

11CytokinesIBA
01/2021 - 01/2006
8salicylhydroxamic acid (SHAM)IBA
03/2017 - 07/2010
6Interleukin-6 (Interleukin 6)IBA
03/2017 - 07/2010
5PlacebosIBA
01/2017 - 07/2010
4Toll-Like Receptors (Toll-Like Receptor)IBA
11/2016 - 09/2011
3Interleukin-10 (Interleukin 10)IBA
03/2017 - 01/2012
3Interleukin-17 (Interleukin 17)IBA
01/2014 - 07/2010
2Toll-Like Receptor AgonistsIBA
11/2016 - 09/2011
2Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
06/2015 - 08/2014
2InterleukinsIBA
06/2015 - 08/2014
2ChemokinesIBA
06/2015 - 11/2012
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
05/2008 - 01/2006
1Small Interfering RNA (siRNA)IBA
01/2022
1IntegrinsIBA
01/2022
1HMGB1 Protein (HMG1)IBA
03/2017
1Fibronectins (Fibronectin)IBA
03/2017
1Hyaluronic Acid (Hyaluronan)IBA
03/2017
1Cytochromes c (Cytochrome c)IBA
03/2017
1Peroxidase (Myeloperoxidase)IBA
06/2015
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
02/2015
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2014
1Tacrolimus (Prograf)FDA LinkGeneric
11/2013
1N(6)-(1-iminoethyl)lysineIBA
11/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2012
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2012
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
11/2012
1CPG-oligonucleotideIBA
09/2011
1ZymosanIBA
09/2011
1Chemokine CCL5IBA
09/2011
1Bromodeoxyuridine (BrdU)IBA
01/2011
1TroponinIBA
07/2010
1Interleukin-22 (IL-22)IBA
07/2010
1Interferon-gamma (Interferon, gamma)IBA
05/2008
1LipopolysaccharidesIBA
10/2007
1Peptidoglycan (Murein)IBA
10/2007

Therapy/Procedure

2Therapeutics
11/2013 - 05/2008
1Blood Transfusion (Blood Transfusions)
01/2019
1Resuscitation
01/2019
1Ligation
05/2008
1Punctures
05/2008
1Immunomodulation
01/2006